After our pieces drew attention to this issue, the sponsor reported a sensitivity analysis [ 14 ]: the p- value changed from highly significant to “barely significant” [ 8 ].
← all excerpts
Efficacy and safety of esketamine for "treatment resistant depression": registered report for a systematic review with an individual patient data meta-analysis of randomized, double-blind, placebo-controlled trials.
1
—
—